polyclonal rabbit anti sirt6 antibody (Cell Signaling Technology Inc)
Structured Review

Polyclonal Rabbit Anti Sirt6 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 172 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti sirt6 antibody/product/Cell Signaling Technology Inc
Average 95 stars, based on 172 article reviews
Images
1) Product Images from "Expression, regulation, and multifaceted molecular and biological functions of sirtuin 6 in the porcine endometrium during early pregnancy"
Article Title: Expression, regulation, and multifaceted molecular and biological functions of sirtuin 6 in the porcine endometrium during early pregnancy
Journal: Cell Communication and Signaling : CCS
doi: 10.1186/s12964-026-02699-1
Figure Legend Snippet: a-c Localization and expression of SIRT6 at the maternal-conceptus interface during early pregnancy. a Immunohistochemical localization of SIRT6 protein in the endometrium of early pregnant gilts (days 10 to 30) and conceptus trophoblast from days 20 and 30 of pregnancy. Positive immunoreaction was observed in luminal (LE) and glandular (GE) epithelium, stromal (ST) cells of endometrium, as well as in the trophoblast (Tr). Arrows indicate nuclear staining. NC – negative control; DP – day of pregnancy; Scale bars, 20 µm. b Expression of SIRT6 mRNA and protein in the endometrium of early pregnant pigs. c Expression of SIRT6 protein in the nuclear fraction of the endometrium. d Effect of conceptus-derived factors on SIRT6 mRNA and protein expression in endometrial explants. Endometrial slices were treated with estradiol (E2; 0.01 and 0.1 µM), prostaglandin E2 (PGE2; 1 and 10 µM), interferon γ (IFNγ; 10 and 50 ng/mL), interleukin 1β (IL1β; 10 and 50 ng/mL), or conceptus-exposed medium (CEM) for 24 h. Values from qPCR were normalized to the geometric mean of GAPDH and HPRT1 gene expression. Values from densitometric analyses of blots were normalized to total protein content using TGX Stain-Free gel technology. All blots are included in Additional File 3: Fig. S4-S6. b and c Data are expressed as the mean ± SEM ( n = 6 per day in each group). Various letters indicate a significant difference between groups ( p < 0.05). d Data are expressed as the mean ± SEM from 5 experiments and presented as a fold change of control values
Techniques Used: Expressing, Immunohistochemical staining, Staining, Negative Control, Derivative Assay, Gene Expression, Control
Figure Legend Snippet: Localization and regulation of SIRT6 expression in luminal epithelial (LE) cells of the porcine endometrium. a Representative images showing SIRT6 protein localization in LE cells. Cells were counterstained with diamidino-2-phenylindole (DAPI) and CytoPainter Phalloidin-iFluor 488 Reagent (iFluor) to visualize nuclei and actin filaments, respectively. NC – negative control; scale bars, 20 µm. Cells were treated with ( b ) estradiol (E2; 0.01 and 0.1 µM), prostaglandin E2 (PGE2; 1 and 10 µM), interferon γ (IFNγ; 10 and 50 ng/mL), interleukin 1β (IL1β; 10 and 50 ng/mL), ( c ) conceptus-exposed medium (CEM), ( d ) E2 (0.1 µM), progesterone (P4; 0.1 µM), or the combination of E2 and P4 for 24 h. Values from qPCR were normalized to the geometric mean of GAPDH and HPRT1 gene expression. Values from densitometric analyses of blots were normalized to the total protein content using TGX Stain-Free gel technology ( b and c ) or to the abundance of beta-actin (ACTB; d ). All blots are included in Additional File 3: Fig. S7. The results are presented as a fold change of the respective control values. Data are expressed as the mean ± SEM from 3–4 ( c ) and 6 ( b and d ) experiments
Techniques Used: Expressing, Negative Control, Gene Expression, Staining, Control
Figure Legend Snippet: The transcriptome of porcine endometrial tissue in response to SIRT6 activation. a Volcano plot with differentially expressed genes (DEGs) in endometrial explants treated with SIRT6 activator, UBCS039, compared to untreated control (adjusted p -value < 0.05 and log2 fold change > 0.58). Green dots and red dots represent up-regulated and down-regulated DEGs, respectively. Grey dots represent genes with no significant difference. b Heatmap showing hierarchical clustering analysis results according to DEGs after UBCS039 treatment of endometrial explants; the top 50 DEGs are shown. Each row represents one gene, and each column represents a sample. The color scale indicates the relative gene expression level, expressed as a z-score, which represents the number of standard deviations from the mean expression of a given gene. Green indicates higher values in gene expression, and red indicates lower values compared with the respective control (CTRL). c The qPCR validation of RNA-sequencing (RNA-seq) data using eleven selected genes. Values from qPCR were normalized to the geometric mean of GAPDH and HPRT1 gene expression. Data are expressed as the log2 fold change of mean expression levels between control and UBCS039-treated endometrial explants ( n = 3 per group). TSPAN15 : tetraspanin 15; F11R : F11 receptor; MMP3 : matrix metallopeptidase 3; FLT1 : fms related receptor tyrosine kinase 1; ANGPT1 : angiopoietin 1; ASNS : asparagine synthetase (glutamine-hydrolyzing); SLC3A2 : solute carrier family 3 member 2; TMED3 : transmembrane p24 trafficking protein 3; UBA5 : ubiquitin like modifier activating enzyme 5; SARS1 : Seryl-tRNA synthetase 1; ACAT1 : acetyl-CoA acetyltransferase 1
Techniques Used: Activation Assay, Control, Gene Expression, Expressing, Biomarker Discovery, RNA Sequencing, Ubiquitin Proteomics
Figure Legend Snippet: Effect of SIRT6 on prostaglandin (PG) E2 concentration and prostaglandin E synthase ( PTGES ) mRNA expression. a and b Endometrial slices were exposed to medium only (control) or medium containing SIRT6 activator (UBCS039; 75 and 100 µM) or inhibitor (OSS_128167; 100 µM and 125 µM) for 24 h. c Arachidonic acid (ARA; 200 µM) was used as a positive control for PGE2 synthesis. d Luminal epithelial (LE) cells were cultured with UBCS039 (100 µM) for 6 and 24 h. PGE2 levels are presented as a fold change of the respective control values. Values from qPCR were normalized to the geometric mean of GAPDH and HPRT1 gene expression. Data are expressed as the mean ± SEM from 4 ( c , d ) or 5 ( a , b ) experiments. Bars with various letters are significantly different ( p < 0.05). Asterisk indicates the difference compared with the control ( p < 0.05)
Techniques Used: Concentration Assay, Expressing, Control, Positive Control, Cell Culture, Gene Expression
Figure Legend Snippet: SIRT6 downregulates the BAX/BCL2 ratio by upregulating the expression of the anti-apoptotic BCL2 gene. Endometrial slices were exposed to medium only (control) or medium containing SIRT6 activator (UBCS039; 75 and 100 µM) or inhibitor (OSS_128167; 125 µM) for 24 h. Values from qPCR were normalized to the geometric mean of GAPDH and HPRT1 gene expression. Data are expressed as the mean ± SEM from 5 experiments. Bars with various letters are significantly different ( p < 0.05)
Techniques Used: Expressing, Control, Gene Expression
Figure Legend Snippet: SIRT6 stimulates luminal epithelial (LE) cell proliferation by promoting cell cycle progression. a and b Effect of SIRT6 on LE cell proliferation. Cells were cultured with SIRT6 activator, UBCS039, or inhibitor, OSS_128167 (50 to 125 µM) for 24 and 48 h. Newborn calf serum (NCS; 20%) was used as a positive control. c and d Effect of SIRT6 on cell cycle distribution and the expression of essential regulators of cell cycle progression. LE cells were treated with either control media or UBCS039 (100 µM). c After 24 h, the percentage of cells in G0/G1, S, and G2/M phases was calculated by fluorescence intensity of incorporated FxCycle Violet Stain in a flow cytometry analysis. Representative images of cell cycle fractions are presented. d After 6 and/or 24 h, cell cycle-related protein levels were determined in cell extracts by Western blot. Values from densitometric analyses of blots were normalized to the abundance of beta-actin (ACTB). Western blots used for densitometric quantifications of cyclins are presented. All blots are included in Additional File 3: Fig. S8. Data are expressed as the mean ± SEM ( n = 3–4). Asterisks indicate differences as compared with the respective control cells (* p < 0.05; ** p < 0.01; **** p < 0.0001). Bars with various letters (ab-for control cells; xy-for UBCS039-treated cells) are significantly different among groups
Techniques Used: Cell Culture, Positive Control, Expressing, Control, Fluorescence, Staining, Flow Cytometry, Western Blot
Figure Legend Snippet: Activation of SIRT6 disrupts the adhesive properties of endometrial luminal epithelial cells. Cells were treated with either control media or UBCS039 (100 µM). Data are expressed as the mean ± SEM ( n = 3). Asterisk indicates difference as compared with the control cells (* p < 0.05)
Techniques Used: Activation Assay, Adhesive, Control
Figure Legend Snippet: Graphical summary of the molecular and biological effects of SIRT6 in the porcine peri-implantation endometrium. Molecules and cellular processes affected by SIRT6 are indicated in green (stimulation) and red (inhibition). A SIRT6 facilitates the transport of serine, glucose, and glutamine via the SLC transporters for metabolism; an intermediate of glycolysis is converted into serine by enzymatic actions of PHGDH, PSAT1, and PSPH, and then into glycine and formate via SHMT2 and MTHFD2; glutamine is converted to α-ketoglutarate (α-KG) by PSAT1 and GPT2, for entry into the TCA cycle. This releases aspartate, which is converted to asparagine via ASNS. SIRT6 may drive the biosynthesis of proline from glutamate by enhancing the activity of ALDH18A1 and PYCR1, and by inhibiting ALDH4A1. B SIRT6 induces the polyamine-spermidine pathway by up-regulating ODC1 and SRM expression and affecting polyamine uptake and transport. C SIRT6 facilitates the import of protein precursors into mitochondria. D SIRT6-affected genes are related to the oxidative phosphorylation (OXPHOS) system and ATP production. E SIRT6 may balance pro- and anti-inflammatory responses; e.g., it inhibits the cytokine-dependent JAK/STAT5/IRF pathway and modulates the levels of anti-inflammatory OSM and pro-inflammatory CSF. SIRT6 regulates the levels of TNF family members and inhibits TRADD, a TNF receptor 1-associated signal transducer. F SIRT6 is essential for intracellular trafficking by facilitating (i) the translocation of proteins across the ER membrane involving the SRP complex, (ii) anterograde and retrograde Golgi trafficking involving COPII and COPI components, and (iii) extracellular vesicle-mediated transport involving RAB proteins. G SIRT6 controls the initiation of translation by inducing the expression of aminoacyl-tRNA-synthetases (aaRS), METTL , and ALKBH1 . H SIRT6 affects extracellular matrix remodeling and impairs adhesion of luminal epithelial cells. I Anti-apoptotic action of SIRT6. J SIRT6 accelerates cell cycle progression through the G2/M phase and promotes cell proliferation. K SIRT6 induces prostaglandin (PG) E2 metabolism. The full names of depicted molecules are listed in Additional file 1: Table S3
Techniques Used: Inhibition, Activity Assay, Expressing, Phospho-proteomics, Translocation Assay, Membrane




